In agreement with previous studies [14], [33], we found that a 12-week supplement of a flaxseed-derived lignan providing 360 mg/day of SDG did not affect blood lipid profiles, insulin resistance, fasting glucose and insulin concentrations in type 2 diabetic patients. This evidence concerns the gene INS and Insulin resistance.